At the 40th anniversary jubilee meeting of the Dutch Pharmacological Society on 1 June in Utrecht, Tom Schirris, theme Mitochondrial diseases received the Prof. Dr. Van Zwieten award for his doctoral thesis, entitled “Identifying on- and off-target mitochondrial drug effects by systems medicine”.
Tom defended his thesis cum laude in December 2016 and he is currently studying the pharmacological aspects of mitochondrial transporters at the MRC Biology Unit of Cambridge University, funded by an EMBO Long-Term Fellowship.More information about the Prof. Dr. Van Zwieten award click here.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Hans Spelbrink is beneficiary of the MITGEST Doctoral Network which receives 2.6 million euros funding (PhD positions available)
27 September 2022EU has granted the new Doctoral Network “MITGEST” (Quality Control of the Mitochondrial Gene Expression System in Health and Disease), of which Radboudumc is one of the partners, with 2.6 million euros of funding under the Marie Sklodowska-Curie Actions.
read moreTowards a better understanding of Leigh Syndrome pathology and intervention published in Brain
8 December 2021 Melissa van de Wal and colleagues recently published a comprehensive review in the journal Brain on how Ndufs4 knockout mouse models have been used to unravel the pathomechanism of Leigh Syndrome. read moreNew genetic defect links cell biology and protein glycosylation
10 November 2021 Peter Linders, Dirk Lefeber and Geert van den Bogaart together with international colleagues have recently reported on novel cell biological insights, by identifying a genetic disorder in syntaxin-5 which allowed to unravel a new mechanism regulating intracellular transportation. read moreMartinus van Marum prize for Tom Schirris
3 April 2020This award of € 12,500 is intended as an incentive prize for researchers who have obtained their PhD degree in 2015 or later. The jury, consisting of members of the Society, came to this decision unanimously.
read more